Godavari Biorefineries Ltd
Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]
- Market Cap ₹ 975 Cr.
- Current Price ₹ 190
- High / Low ₹ 409 / 145
- Stock P/E 78.7
- Book Value ₹ 78.1
- Dividend Yield 0.00 %
- ROCE 7.40 %
- ROE 2.50 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Tax rate seems low
- Company has a low return on equity of 3.64% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Part of BSE Fast Moving Consumer Goods BSE SmallCap BSE IPO BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 1,459 | 1,538 | 1,702 | 2,015 | 1,687 | |
| 1,356 | 1,381 | 1,568 | 1,867 | 1,553 | |
| Operating Profit | 103 | 158 | 135 | 147 | 134 |
| OPM % | 7% | 10% | 8% | 7% | 8% |
| 14 | 8 | 6 | 7 | 14 | |
| Interest | 69 | 72 | 60 | 73 | 76 |
| Depreciation | 45 | 47 | 48 | 50 | 60 |
| Profit before tax | 3 | 46 | 33 | 32 | 12 |
| Tax % | -24% | 41% | 40% | 38% | 1% |
| 4 | 27 | 19 | 20 | 12 | |
| EPS in Rs | 0.97 | 6.47 | 4.64 | 4.68 | 2.93 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 3% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -22% |
| TTM: | -39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 4% |
| Last Year: | 3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 42 | 42 | 42 | 42 | 42 | 42 |
| Reserves | 385 | 412 | 431 | 448 | 459 | 358 |
| 589 | 569 | 637 | 736 | 655 | 685 | |
| 418 | 419 | 623 | 518 | 836 | 271 | |
| Total Liabilities | 1,434 | 1,442 | 1,733 | 1,744 | 1,992 | 1,356 |
| 735 | 708 | 667 | 866 | 850 | 845 | |
| CWIP | 17 | 9 | 50 | 17 | 29 | 33 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| 683 | 725 | 1,016 | 860 | 1,113 | 478 | |
| Total Assets | 1,434 | 1,442 | 1,733 | 1,744 | 1,992 | 1,356 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 250 | 130 | 45 | 197 | 186 | |
| -23 | -7 | -47 | -214 | -44 | |
| -226 | -121 | 4 | 28 | -151 | |
| Net Cash Flow | 1 | 2 | 3 | 11 | -10 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 31 | 40 | 39 | 37 | 41 |
| Inventory Days | 130 | 146 | 200 | 137 | 250 |
| Days Payable | 123 | 132 | 176 | 105 | 195 |
| Cash Conversion Cycle | 39 | 55 | 63 | 68 | 95 |
| Working Capital Days | 44 | 57 | 72 | 52 | 50 |
| ROCE % | 12% | 9% | 9% | 7% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
14 May - Q4 and FY25 earnings call scheduled for May 26, 2025, at 11 AM IST.
-
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31, 2025
8 May - Board meeting on May 24 to approve FY25 results; trading window closed from April 1 till post-results.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
29 Apr - Godavari Biorefineries states it is not a 'Large Corporate' under SEBI debt issuance framework.
-
Update Details Of Registrar And Transfer Agent
18 Apr - Change in RTA email and website details
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16 Apr - Rescheduling of analyst/investor meeting to 22nd April 2025.
Annual reports
Concalls
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
Business Overview:[1][2]
a) GBL is a part of the Somaiya group which holds 63.31% equity stake in the company through entities.
b) It has an Integrated Bio-refinery across value chain viz. Sugar, Branded Sugar, Ethanol, Bio Based Chemicals & Power
c) It has India’s first bio-based Ethyl Vinyl Ether (EVE) manufacturing facility in India
d) Company is the largest Manufacturer of MPO in India in terms of installed capacity
e) It is one of only 2 Manufacturers of natural 1,3 Butylene Glycol (BG) globally
f) The company has an in-house retail brand Jivana for sale of sugar, turmeric, and salt in Rajasthan Maharashtra, Karnataka, and Gujarat.